Last reviewed · How we verify

rFSH: Follicle Stimulating Hormone

Instituto Valenciano de Infertilidad, IVI VALENCIA · Phase 3 active Small molecule

rFSH: Follicle Stimulating Hormone is a Gonadotropin Small molecule drug developed by Instituto Valenciano de Infertilidad, IVI VALENCIA. It is currently in Phase 3 development for Induction of ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders, Assisted reproductive technology (ART) such as in vitro fertilization (IVF).

rFSH stimulates follicular growth and maturation in the ovaries.

rFSH stimulates follicular growth and maturation in the ovaries. Used for Induction of ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders, Assisted reproductive technology (ART) such as in vitro fertilization (IVF).

At a glance

Generic namerFSH: Follicle Stimulating Hormone
SponsorInstituto Valenciano de Infertilidad, IVI VALENCIA
Drug classGonadotropin
TargetFSH receptor
ModalitySmall molecule
Therapeutic areaReproductive Health
PhasePhase 3

Mechanism of action

rFSH acts by binding to the FSH receptor on the surface of granulosa cells in the ovaries, triggering a cascade of downstream effects that promote follicular growth and maturation. This ultimately leads to the release of an ovum from the ovary, making it available for fertilization.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about rFSH: Follicle Stimulating Hormone

What is rFSH: Follicle Stimulating Hormone?

rFSH: Follicle Stimulating Hormone is a Gonadotropin drug developed by Instituto Valenciano de Infertilidad, IVI VALENCIA, indicated for Induction of ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders, Assisted reproductive technology (ART) such as in vitro fertilization (IVF).

How does rFSH: Follicle Stimulating Hormone work?

rFSH stimulates follicular growth and maturation in the ovaries.

What is rFSH: Follicle Stimulating Hormone used for?

rFSH: Follicle Stimulating Hormone is indicated for Induction of ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders, Assisted reproductive technology (ART) such as in vitro fertilization (IVF).

Who makes rFSH: Follicle Stimulating Hormone?

rFSH: Follicle Stimulating Hormone is developed by Instituto Valenciano de Infertilidad, IVI VALENCIA (see full Instituto Valenciano de Infertilidad, IVI VALENCIA pipeline at /company/instituto-valenciano-de-infertilidad-ivi-valencia).

What drug class is rFSH: Follicle Stimulating Hormone in?

rFSH: Follicle Stimulating Hormone belongs to the Gonadotropin class. See all Gonadotropin drugs at /class/gonadotropin.

What development phase is rFSH: Follicle Stimulating Hormone in?

rFSH: Follicle Stimulating Hormone is in Phase 3.

What are the side effects of rFSH: Follicle Stimulating Hormone?

Common side effects of rFSH: Follicle Stimulating Hormone include Ovarian hyperstimulation syndrome (OHSS), Multiple pregnancy, Headache, Nausea and vomiting, Abdominal pain.

What does rFSH: Follicle Stimulating Hormone target?

rFSH: Follicle Stimulating Hormone targets FSH receptor and is a Gonadotropin.

Related